FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, more specifically to pharmacology, and concerts agents having an effect on the rheological properties of blood. What is presented is using the chemical modification product of hydroxyethylated starch O-(2-hydroxyethyl)-(1,4)-α-D-glucan, the hybrid macromolecular compound O-(4-hydroxy-3,5-di(1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl)benzyl)oxy)ethyl)-O-(2-hydroxyethyl)-(1,4)-α-D-glucan as an agent improving the rheological properties of blood. The invention can be used in a complex therapy of pathologies accompanied by blood hyperviscosity.
EFFECT: limiting an increase in blood viscosity.
4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MEANS FOR CEREBRAL BLOOD FLOW INCREASE | 2016 |
|
RU2655810C2 |
| PHARMACEUTICAL INJECTION FORM OF HYDROPHILIC CONJUGATE OF HYDROXYETHYLAMYLUM AND 2,6-DIISOBORNYL-4-METHYLPHENOL, METHOD FOR ITS PRODUCTION AND APPLICATIONS FOR CARDIOVASCULAR DISEASES TREATMENT | 2016 |
|
RU2625039C1 |
| AGENT POSSESSING NEUROPROTECTIVE ACTIVITY | 2018 |
|
RU2701739C1 |
| AGENT EHXIBITING HAEMORHEOLOGIC ACTIVITY | 2011 |
|
RU2473348C1 |
| AGENTS EHXIBITING HAEMORHEOLOGIC ACTIVITY | 2010 |
|
RU2425683C1 |
| ERYTHROPROTECTIVE AGENT FOR PHENYLHYDRAZINE POISONING | 2011 |
|
RU2471488C1 |
| PREPARATIONS IMPROVING SURVIVAL RATE IN WOUND SHOCK | 2011 |
|
RU2471489C1 |
| NOVEL DERIVATIVES OF 2,6-DI-ISOBORNYL PHENOL AND METHOD OF OBTAINING THEREOF | 2012 |
|
RU2516699C2 |
| DRUG WITH COMPLEX PHARMACOLOGICAL EFFECT FOR THE TREATMENT OF CARDIOVASCULAR DISEASES, CORRECTION OF CEREBRAL CIRCULATION DISORDERS, TREATMENT OF CONSEQUENCES OF CEREBROVASCULAR DISEASES (OPTIONS) | 2019 |
|
RU2757874C1 |
| HYDROPHILIC CONJUGATE OF HYDROXYETHYL STARCH AND 2,6-DIISOBORNYL-4-METHYLPHENOL | 2012 |
|
RU2497828C1 |
